Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine sulphate prolonged-release capsules versus methadone for maintenance treatment of opioid addiction
2005-004482-41Phase 3Terminated
- Sponsor
- Napp Pharmaceuticals
- Start
- Dec 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid use disorder (OUD) comparing MXL once daily with Methadose once daily (2 arms). Primary endpoints: Reduction of illicit heroin use and Retention rate at end of maintenance treatment. Started Dec 2005; status: terminated.
02
Drugs
morphinemethadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2005-004482-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004482-41.